Female-oriented programmes in addiction care - Results from the Ad-femina survey

 

eftacmz3.jpg

Tendances n° 130, OFDT, 6 p.
March 2019

As a minority in specialised care services, French women presenting with addictions represent 23% and 18% of the public seen in specialised drug treatment centres (CSAPA) and harm reduction facilities (CAARUD) respectively. However, these women show, more than men, many social and health vulnerability factors (suicidal history, psychiatric comorbidity and an abnormally high death rate related to drug use, single parenthood, violence, etc.) and report a greater fear of being stigmatised. When facing these situations, which can be exacerbated during pregnancy or when children are involved, addiction care services have sometimes developed specific care arrangements to meet women's needs. These specific answers take various forms: from ad hoc interventions to the implementation of a framework of follow-up and appropriate care. In 2018, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) launched the Ad-femina online survey to provide an overview of addiction schemes tailored specifically to women in 2017 in France.

About 2,650 women were seen in 80 schemes in 2017, a modest number compared to around 72,000 women who annually attend CSAPAs and CAARUDs. Like all women received in specialised services, these beneficiaries are mainly polydrug users, often misuse alcohol and have social and health vulnerabilities, deterring them from asking for care. Finding ways to get them into care as early as possible and keeping regular contact with them are some of the main challenges faced by the teams.

Author : Carine Mutatayi

Download the PDF file (608 Ko)

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.